Most profitable U.S. drug and biologic companies. Ranked by 2013 profit margin
Modern healthcare Suppl: 30
2014
ISSN/ISBN: 0160-7480 PMID: 25831880 Document Number: 671893
Document emailed within 1 workday
Related Documents
2009: By the numbers. Most profitable critical-access hospitals. Ranked by operating margin for fiscal 2007 Modern Healthcare 39(18): 342015: Top 10 development companies. Ranked by 2014 dollar volume Modern healthcare Suppl Dec 21 2015: 36
2010: Largest healthcare financing companies. Ranked by amount of loans underwritten in 2009 Modern healthcare 40(48): 34
Moon, S. 2005: By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, November 2003 to October 2004 Modern Healthcare 35(1): 32
Nid, P. 2016: Largest not-for-profit healthcare systems. Ranked by total operating revenue for 2015 Modern Healthcare 46(25): 34
2015: Largest not-for-profit hospital systems. Ranked by total operating revenue for 2014 Modern healthcare Suppl Dec 21 2015: 5
Limbacher, P.B. 1998: Off the beaten path. more for-profit hospital companies traveling to rural markets Modern Healthcare 28(14): 67-72
Chren, M.M. 1994: Independent investigators and for-profit companies. Guidelines for biomedical scientists considering funding by industry Archives of Dermatology 130(4): 432-437
Chren, M.M.; Landefeld, C.S. 1991: Doctors, drug companies and gifts Rhode Island Medical Journal 74(12): 603-610
Charatan, F. 2001: Doctors say they are not influenced by drug companies' promotions Bmj 322(7294): 1081
Yamey, G. 2001: Pen "amnesty" for doctors who shun drug companies Bmj 322(7278): 69
Heimoff, S. 2000: Disease management. Getting out from under drug companies' shadows Managed Care 9(3): 39-40; 42-43
Charatan, F. 2001: Drug companies defrauded Medicare of millions Bmj 323(7317): 828
2011: Targeting drug companies' bottom line Prescrire International 20(112): 25
2012: Key opinion leaders: used as a marketing tool by drug companies Prescrire International 21(128): 163-165
Bellizzi, V.; Perrone, F.; Terracciano, V.; Cucciniello, E.; Stanzione, G.; D'Angiò, P.; De Nicola, L.; Di Iorio, B. 2008: Survey of hidden costs of dialysis in Italian for-profit and not-for-profit centers Journal of Nephrology 21(6): 894-899
1994: For U.S. drug companies' products sold in developing countries, labeling is often inadequate American Journal of Hospital Pharmacy 51(7): 875-876
von Lutterotti, N. 2003: Patients in the profit trap? America's clinical status: when profit motivation increases mortality rate Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 74(6): M180-M181
Phillips, J.F. 1999: For-profit chains seek to acquire successful not-for-profit hospitals Healthcare Financial Management: Journal of the Healthcare Financial Management Association 53(9): 52-55
2010: Drug companies monitor prescriptions and sales to fine-tune their marketing strategies Prescrire International 19(107): 140-141